Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients

Page, D. B., Diab, A., Yuan, J., Dong, Z., Soloman, S. B., Patil, S., … McArthur, H. L. (2015). Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients. Journal for ImmunoTherapy of Cancer, 3. https://doi.org/10.1186/2051-1426-3-S1-O6